(Q41444647)

English

Performance and reliability of the SYBR Green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates

scientific article published on 5 March 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 September 2017

Performance and reliability of the SYBR Green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates (English)

1 reference

Europe PubMed Central

30 September 2017

Plasmodium falciparum

0 references

5

1 reference

Europe PubMed Central

30 September 2017

author name string

Marie Ange Rason

1

1 reference

Europe PubMed Central

30 September 2017

Tantely Randriantsoa

2

1 reference

Europe PubMed Central

30 September 2017

Herilalaina Andrianantenaina

3

1 reference

Europe PubMed Central

30 September 2017

Arsène Ratsimbasoa

4

1 reference

Europe PubMed Central

30 September 2017

publication date

5 March 2008

1 reference

Europe PubMed Central

30 September 2017

Transactions of the Royal Society of Tropical Medicine and Hygiene

1 reference

Europe PubMed Central

30 September 2017

102

1 reference

Europe PubMed Central

30 September 2017

4

1 reference

Europe PubMed Central

30 September 2017

346-351

1 reference

Europe PubMed Central

30 September 2017

Measurement in Medicine: The Analysis of Method Comparison Studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.021

7 January 2021

Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.021

7 January 2021

Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.021

7 January 2021

Public health impact of drug resistant Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.021

7 January 2021

Conquering the intolerable burden of malaria: what's new, what's needed: a summary.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.021

7 January 2021

Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.021

7 January 2021

A colorimetric in vitro drug sensitivity assay for Plasmodium falciparum based on a highly sensitive double-site lactate dehydrogenase antigen-capture enzyme-linked immunosorbent assay.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.021

7 January 2021

Use of radioactive ethanolamine incorporation into phospholipids to assess in vitro antimalarial activity by the semiautomated microdilution technique

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.021

7 January 2021

The global distribution and population at risk of malaria: past, present, and future

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.021

7 January 2021

Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.021

7 January 2021

Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.021

7 January 2021

Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.021

7 January 2021

Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.021

7 January 2021

Histidine-rich protein II: a novel approach to malaria drug sensitivity testing

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.021

7 January 2021

Malaria drug-sensitivity testing: new assays, new perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.021

7 January 2021

Immunocapture diagnostic assays for malaria using Plasmodium lactate dehydrogenase (pLDH).

2 references

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.021

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.021

7 January 2021

based on heuristic

inferred from DOI database lookup

Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.021

7 January 2021

The global distribution of clinical episodes of Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.021

7 January 2021

A molecular marker for chloroquine-resistant falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.021

7 January 2021

Identifiers

10.1016/J.TRSTMH.2008.01.021

1 reference

Europe PubMed Central

30 September 2017

1 reference

Europe PubMed Central

30 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41444647&oldid=2097796644"